Early Experience of Combination Treatment of Sorafenib and Radiotherapy in Advanced Hepatocellular Carcinoma Patients

被引：1
|
作者：
Cha, J. [1 ]
Seong, J. [1 ]
Han, K. [1 ]
机构：
[1] Yonsei Univ Hlth Syst, Seoul, South Korea
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2010年 / 78卷 / 03期
关键词：
D O I：
10.1016/j.ijrobp.2010.07.727
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S306 / S307
页数：2
相关论文
共 50 条
  • [41] Sorafenib in advanced hepatocellular carcinoma
    Sauerbruch, T.
    Gonzalez-Carmona, A. M.
    Nitschmann, S.
    INTERNIST, 2009, 50 (11): : 1290 - 1292
  • [42] Sorafenib in advanced hepatocellular carcinoma
    Llovet, Josep M.
    Ricci, Sergio
    Mazzaferro, Vincenzo
    Hilgard, Philip
    Gane, Edward
    Blanc, Jean-Frederic
    Cosme de Oliveira, Andre
    Santoro, Armando
    Raoul, Jean-Luc
    Forner, Alejandro
    Schwartz, Myron
    Porta, Camillo
    Zeuzem, Stefan
    Bolondi, Luigi
    Greten, Tim F.
    Galle, Peter R.
    Seitz, Jean-Francois
    Borbath, Ivan
    Haussinger, Dieter
    Giannaris, Tom
    Shan, Minghua
    Moscovici, Marius
    Voliotis, Dimitris
    Bruix, Jordi
    NEW ENGLAND JOURNAL OF MEDICINE, 2008, 359 (04): : 378 - 390
  • [43] Sorafenib for Advanced Hepatocellular Carcinoma
    Shingina, Alexandra
    Hashim, ALMoutaz
    Haque, Mazhar
    Suen, Michael W.
    Yoshida, Eric M.
    Gill, Sharlene
    Weiss, Alan
    GASTROENTEROLOGY, 2012, 142 (05) : S42 - S42
  • [44] Survival Benefit of Long-Term Sorafenib Treatment in Patients with Advanced Hepatocellular Carcinoma in Indonesia: Multicenter experience
    Lesmana, Cosmas R.
    Gani, Rino A.
    Pakasi, Levina S.
    Hasan, Irsan
    Waspodo, Agus S.
    Siregar, Lianda
    Budi, Poernomo
    Lesmana, Laurentius A.
    HEPATOLOGY, 2014, 60 : 866A - 867A
  • [45] Sunitinib in Patients with Advanced Hepatocellular Carcinoma after Progression under Sorafenib Treatment
    Woerns, Marcus Alexander
    Schuchmann, Marcus
    Dueber, Christoph
    Otto, Gerd
    Galle, Peter Robert
    Weinmann, Arndt
    ONCOLOGY, 2010, 79 (1-2) : 85 - 92
  • [46] SORAFENIB THERAPY FOR ADVANCED HEPATOCELLULAR CARCINOMA: SINGLE-CENTER EXPERIENCE ON 43 PATIENTS
    Zimmermann, Lars
    Csepregi, Antol
    HEPATOLOGY, 2008, 48 (04) : 503A - 503A
  • [47] A single center experience of sorafenib in advanced hepatocellular carcinoma patients: evaluation of prognostic factors
    Song, Tianqiang
    Zhang, Wei
    Wu, Qiang
    Kong, Dalu
    Ma, Weiwei
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2011, 23 (12) : 1233 - 1238
  • [48] Value of α-fetoprotein as an early biomarker for treatment response to sorafenib therapy in advanced hepatocellular carcinoma
    Plano Sanchez, Ana Isabel
    Velasco Roces, Lucia
    Zapico Garcia, Isabel
    Lazaro Lopez, Eva
    Calleja Hernandez, Miguel Angel
    Baena Parejo, Maria Isabel
    Pena-Diaz, Jaime
    ONCOLOGY LETTERS, 2018, 15 (06) : 8863 - 8870
  • [49] Indicators of sorafenib efficacy in patients with advanced hepatocellular carcinoma
    Masayoshi Yada
    Akihide Masumoto
    Kenta Motomura
    Hirotaka Tajiri
    Yusuke Morita
    Hideo Suzuki
    Takeshi Senju
    Toshimasa Koyanagi
    World Journal of Gastroenterology, 2014, (35) : 12581 - 12587
  • [50] Indicators of sorafenib efficacy in patients with advanced hepatocellular carcinoma
    Yada, Masayoshi
    Masumoto, Akihide
    Motomura, Kenta
    Tajiri, Hirotaka
    Morita, Yusuke
    Suzuki, Hideo
    Senju, Takeshi
    Koyanagi, Toshimasa
    WORLD JOURNAL OF GASTROENTEROLOGY, 2014, 20 (35) : 12581 - 12587
12345